Carboprost is a synthetic prostaglandin F2α analogue utilized clinically as a potent vasoconstrictor and uterotonic agent to treat postpartum uterine hemorrhage resulting from uterine atony. This category… Read more
![Chemical structure of (3aR,4R,5R,6aS)-4-((E)-3-Hydroxy-3-methyloct-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2418538-08-4-3aR4R5R6aS-4-E-3-Hydroxy-3-methyloct-1-en-1-yl-2-oxohexahydro-2H-cyclopentabfuran-5-yl-11-biphenyl-4-carboxylate.png&w=3840&q=75)
![Chemical structure of (3aR,4R,5R,6aS)-4-((E)-3-Hydroxy-3-methyloct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2,5-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2418538-10-8-3aR4R5R6aS-4-E-3-Hydroxy-3-methyloct-1-en-1-ylhexahydro-2H-cyclopentabfuran-25-diol.png&w=3840&q=75)








Carboprost is a synthetic prostaglandin F2α analogue utilized clinically as a potent vasoconstrictor and uterotonic agent to treat postpartum uterine hemorrhage resulting from uterine atony. This category offers high-quality reference standards for Carboprost, including its trometamol salt, as well as a range of pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, impurity profiling, and method validation to ensure the quality and consistency of the drug substance. By providing access to specific degradation products and metabolites, these standards support the precise identification and quantification of impurities throughout the drug development and manufacturing lifecycle, facilitating strict adherence to regulatory quality control requirements for prostaglandin-based therapeutics.